Haymaker Acquisition Corp. III
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
Money in, money out
What Haymaker Acquisition Corp. III sold, what it kept, and what it did with the cash.
Sales went from $0 in 2024 to $0 in 2025, with -$1.47 million of profit last year.
Haymaker Acquisition Corp. III vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Haymaker Acquisition Corp. III | No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Haymaker Acquisition Corp. III's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2024 | 2025 |
|---|---|---|
| 0 | 0 | |
| – | – | |
| -1 | -3 | |
| -1 | -3 | |
| 11 | -1 | |
| 0.38 | – | |
| – | – | |
| – | – | |
| – | – |
Balance sheet
| In millions of USD | 2024 | 2025 |
|---|---|---|
| Total assets | 250 | 258 |
| Cash | 0 | 0 |
| Total debt | 0 | 3 |
| Total liabilities | 9 | 23 |
| 241 | 235 | |
| 30 | – | |
| -0.3% | -0.9% | |
| 4.7% | -0.6% |
Cash flow
| In millions of USD | 2024 | 2025 |
|---|---|---|
| -0 | -1 | |
| – | – | |
| -0 | -1 | |
| Dividends paid | – | – |
| 0 | 4 | |
| – | – |
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 30, 2026 | 0.05 | 0.05 | +0.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Haymaker Acquisition Corp. III
Is Haymaker Acquisition Corp. III a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Haymaker Acquisition Corp. III AI analysis
What does Haymaker Acquisition Corp. III do?
Haymaker Acquisition Corp. III is presently without substantial commercial operations. Established in 2020, this New York-based entity's primary objective is to acquire and manage a business operating in the consumer or consumer-related products and services industries. It is in Shell Companies.
Does Haymaker Acquisition Corp. III pay a dividend?
No. Haymaker Acquisition Corp. III does not pay a dividend at the moment; in 2025 it returned $4.14 million to shareholders by buying back its own shares.
Is Haymaker Acquisition Corp. III stock halal?
Questionable. Haymaker Acquisition Corp. III sits in a grey zone: scholars disagree about its industry. How we check
Who are Haymaker Acquisition Corp. III's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Haymaker Acquisition Corp. III's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.